Why Earnings Season Could Be Great for FibroGen (FGEN)

Investors are always looking for stocks that are poised to beat at earnings season and FibroGen, Inc. FGEN may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because FibroGen is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for FGEN in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 79 cents per share for FGEN, narrower than the broader Zacks Consensus Estimate of a loss of 90 cents per share. This suggests that analysts have very recently bumped up their estimates for FGEN, giving the stock a Zacks Earnings ESP of +12.17% heading into earnings season.

FibroGen, Inc Price and EPS Surprise

FibroGen, Inc Price and EPS Surprise
FibroGen, Inc Price and EPS Surprise

FibroGen, Inc price-eps-surprise | FibroGen, Inc Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that FGEN has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for FibroGen, and that a beat might be in the cards for the upcoming report.

+1,500% Growth: One of 2021’s Most Exciting Investment Opportunities

In addition to the stocks you read about above, would you like to see Zacks’ top picks to capitalize on the Internet of Things (IoT)? It is one of the fastest-growing technologies in history, with an estimated 77 billion devices to be connected by 2025. That works out to 127 new devices per second.

Zacks has released a special report to help you capitalize on the Internet of Things’s exponential growth. It reveals 4 under-the-radar stocks that could be some of the most profitable holdings in your portfolio in 2021 and beyond.

Click here to download this report FREE >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

FibroGen, Inc (FGEN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research